Which UK Prescription Weight Loss Treatment Suits You?
Understanding Wegovy or Mounjaro UK Prescription Weight Loss Mechanisms
When comparing Wegovy or Mounjaro UK options, the fundamental difference lies in how these prescription-only medicines work at the cellular level. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, working primarily on appetite centres in the brain to reduce hunger and promote satiety after smaller meals. Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously, creating a dual-pathway approach to weight management that may affect both appetite regulation and glucose metabolism.
Both treatments require weekly injections and must be used alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management programme. The choice between Wegovy or Mounjaro UK treatments often comes down to individual response, medical history, and prescriber recommendation. Clinical studies show both can support significant weight loss, though they work through different biological pathways and may suit different patient profiles.
Wegovy or Mounjaro UK Pricing: Complete Cost Breakdown
EverydayMeds offers competitive pricing for both Wegovy or Mounjaro UK treatments, with Wegovy starting at £79.99 for the 0.25mg starter dose. Our Wegovy pricing structure follows the mandatory dose escalation: 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99 per pen. Bundle options provide convenience for longer treatment periods, such as our Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first 12 weeks of treatment in a single order.
New customers benefit from discount code FIRST40 applied at checkout, whilst returning customers use DOSE25 for ongoing orders. Mounjaro pricing varies by dose, with both treatments requiring clinical assessment and prescription through our GPhC-registered pharmacy (#9012878). Our bundle options focus on convenience rather than cost savings, ensuring Reliable Supply continuity and reducing the frequency of orders during your weight management journey.
Clinical Evidence Supporting Wegovy or Mounjaro UK Treatments
The STEP trial programme demonstrates Wegovy's clinical efficacy, with STEP 1 showing approximately 15% average weight loss at 68 weeks versus 2.4% with placebo, when used alongside diet and exercise modifications. STEP 3 achieved around clinically studied weight loss with intensive behavioural therapy, whilst STEP 5 maintained clinically studied weight loss at two years, according to Wilding et al., NEJM, 2021.
Mounjaro's SURMOUNT trials show its own clinical profile, though direct comparison between Wegovy or Mounjaro UK trial results isn't appropriate due to different study designs, populations, and endpoints. Both treatments have undergone rigorous MHRA evaluation and represent evidence-based options for prescription weight loss management when conventional approaches prove insufficient.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy's semaglutide acts as a GLP-1 receptor agonist, binding to the same receptors as your natural incretin hormones that regulate appetite and food intake. When you eat, GLP-1 is naturally released from intestinal cells, signalling fullness to your brain and slowing gastric emptying to maintain satisfaction longer. Wegovy amplifies this natural process, helping reduce the urge to eat between meals and making it easier to feel satisfied with smaller portions. The medication works on hypothalamic appetite centres, potentially reducing food cravings and the psychological drive to eat. This mechanism supports sustainable weight management when combined with lifestyle modifications, as it addresses both physiological hunger signals and eating behaviours that contribute to weight gain.
EverydayMeds Ordering Process for Wegovy or Mounjaro UK
Starting either Wegovy or Mounjaro UK treatment through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and eligibility criteria. Our UK-registered prescribers review applications within 3 working days (or 24 hours with express service), ensuring appropriate prescribing based on MHRA licensing requirements and NICE guidance. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled packaging to maintain medication integrity. Our pharmacy team coordinates with cold-chain logistics to ensure your treatment arrives in optimal condition, with tracking information provided throughout the delivery process. Payment processing includes automatic application of relevant discount codes, with all orders fulfilled through our GPhC-registered pharmacy (#9012878).
Storage and Practical Considerations for Wegovy or Mounjaro UK
Storage requirements differ between Wegovy or Mounjaro UK options, with Wegovy offering superior travel flexibility through its 6-week room temperature stability once removed from refrigeration, compared to Mounjaro's 21-day limit. Both treatments require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature tolerance makes it more suitable for business travel, holidays, or situations where refrigeration access may be limited. The FlexTouch pen system used by Wegovy provides dose accuracy and ease of administration, with clear dose markings and automatic needle insertion. Dose escalation follows a structured schedule over 16 weeks, reaching the 2.4mg maintenance dose, with each strength requiring separate pen systems. Proper disposal through pharmacy return schemes ensures environmental responsibility and medication security.
Wegovy or Mounjaro UK: Personalised Treatment Selection
The decision between Wegovy or Mounjaro UK treatments should reflect individual medical circumstances, treatment goals, and lifestyle factors rather than general population preferences. Patients with type 2 diabetes may find different benefits from each treatment's glucose-related effects, whilst those prioritising travel flexibility might prefer Wegovy's storage advantages. Some individuals respond better to single-pathway GLP-1 stimulation, whilst others may benefit from Mounjaro's dual-receptor approach.
Prescriber consultation remains essential in determining the most appropriate choice between Wegovy or Mounjaro UK options. Factors including cardiovascular risk, gastrointestinal tolerance, injection frequency preferences, and insurance coverage all influence treatment selection. Both medications require commitment to lifestyle modifications and regular monitoring, making prescriber-patient partnership crucial for optimal outcomes.
Next Steps: Starting Your Wegovy or Mounjaro UK Journey
Ready to explore Wegovy or Mounjaro UK prescription weight loss options? Begin with EverydayMeds' clinical assessment at https://everydaymeds.co.uk/collections/wegovy, where our prescribers can evaluate your eligibility and recommend the most suitable treatment. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 for continued care. Both treatments represent significant advances in prescription weight management, offering evidence-based support for sustainable weight loss when combined with comprehensive lifestyle changes. Our clinical team provides ongoing support throughout your treatment journey, ensuring safe and effective use of these prescription-only medicines. Remember that weight management is a long-term commitment, and both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
